| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $2,141,239 ) |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 27 | HRSA | 12/2/2022 | $354,218 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 000 | 1 | SAMHSA | 11/30/2022 | $600,000 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 2 | NIH | 11/29/2022 | $348,965 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 000 | 1 | SAMHSA | 11/30/2022 | $600,000 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 000 | 4 | NIH | 11/14/2022 | $434,649 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03AG079945 | Does age-dependent PFKFB3 down-regulation alter adipose tissue function | 000 | 1 | NIH | 11/3/2022 | $72,500 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA163649 | Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer | 002 | 9 | NIH | 12/5/2022 | $57,112 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK129255 | Targeting kidney resident macrophage niche filling to slow cystic kidney disease | 000 | 1 | NIH | 10/25/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79FG000747 | Behavioral Health Child Life Services Expansion | 001 | 1 | SAMHSA | 12/6/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79FG000747 | Behavioral Health Child Life Services Expansion | 000 | 1 | SAMHSA | 11/1/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 000 | 1 | NIH | 10/18/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA050990 | Impact of a reduced nicotine standard on young adult appeal for menthol and non-menthol cigarettes | 000 | 3 | NIH | 10/17/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30HL149279 | Molecular and in vivo Determinants of p66Shc-Mediated ROS Function in Cardiovascular Health | 000 | 4 | NIH | 11/23/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H4B15502 | Poison Control Stabilization and Enhancement Program | 01 | 14 | HRSA | 10/12/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30AG050911 | Oklahoma Nathan Shock Center of Excellence in Basic Biology of Aging | 000 | 8 | NIH | 10/20/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM103639 | Mentoring Translational Cancer Research in Oklahoma | 000 | 10 | NIH | 11/18/2022 | $0 |
| | 2023 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA163649 | Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer | 002 | 9 | NIH | 12/5/2022 | $4,879 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY032931 | Dysregulation of Wnt signaling in subretinal fibrosis in AMD | 000 | 1 | NIH | 11/17/2022 | -$34,505 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | 90DDC50051 | Expanding Disabilities Network's (UCEDD's): Access to COVID 19 Vaccines | 01 | 1 | ACL | 10/27/2022 | -$59,701 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA213278 | Reprogramming Tumor Microenvironment by Nanoparticle | 000 | 5 | NIH | 10/21/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA213987 | Safer Approaches to CRC Chemoprevention | 001 | 5 | NIH | 10/19/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA213987 | Safer Approaches to CRC Chemoprevention | 000 | 5 | NIH | 10/19/2022 | $0 |
| | 2023 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA200126 | Targeting HPV Consequences in a Cervical Cancer Clinical Trial | 000 | 6 | NIH | 10/12/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK059599 | Regulation of calcium signaling by the PKD2 gene product | 000 | 16 | NIH | 10/13/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30HL142232 | Receptor binding and signaling of the cardioprotective peptide Adrenomedullin 2/Intermedin. | 000 | 2 | NIH | 11/23/2022 | -$1,203 |
| | 2023 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY029240 | Dynamics of the Ocular Immune Response During Uveitis | 000 | 2 | NIH | 11/9/2022 | $0 |
| | 2023 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F30HL134210 | Role of Neural Podoplanin-Activated Platelets in Vascular Development in the Brain | 000 | 4 | NIH | 11/23/2022 | -$10,730 |
| | 2023 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY027754 | The Role of Endoplasmic Reticulum Calcium Channels in Cone Degeneration Resulting from CNG Channel Deficiency | 000 | 4 | NIH | 11/23/2022 | -$6,857 |
| | 2023 | 2019 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | 90YR0115 | Association Between Health-Enhancing Community Environment and Early Childhood Education Classroom Health Practices | 05 | 1 | ACF | 11/7/2022 | -$2,164 |
| | 2023 | 2019 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0028 | UCEDD | 02 | 1 | ACL | 11/18/2022 | -$129,613 |
| | 2023 | 2018 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | 90DDUC0028 | UCEDD | 02 | 1 | ACL | 11/18/2022 | -$86,311 |
|
| Issue Date FY: 2022 ( Subtotal = $76,129,372 ) (Continued on the next page) |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | T9933558 | Value-Based Medical Student Education Training Program | 02 | 4 | HRSA | 8/8/2022 | $34,685 |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy STE 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | T9933558 | Value-Based Medical Student Education Training Program | 01 | 4 | HRSA | 8/2/2022 | $0 |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy STE 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | T9933558 | Value-Based Medical Student Education Training Program | 00 | 4 | HRSA | 5/20/2022 | $1,175,832 |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | T3442150 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 01 | 2 | HRSA | 8/18/2022 | $4,245 |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy STE 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | T3442150 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 2 | HRSA | 5/12/2022 | $431,433 |
| | 2022 | 2022 | University Of Oklahoma | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | UH735353 | Regional Genetics Networks | 00 | 3 | HRSA | 3/28/2022 | $589,495 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 01 | 4 | HRSA | 8/24/2022 | $47,500 |
| | 2022 | 2022 | University of Oklahoma | 865 Research Pkwy STE 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 00 | 4 | HRSA | 5/24/2022 | $749,221 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R50CA233186 | The role of DCLK1 in the initiation of pancreatic ductal adenocarcinoma and colorectal cancer | 000 | 5 | NIH | 8/8/2022 | $89,655 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 000 | 1 | NIH | 9/22/2022 | $37,071 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00HD100554 | Integrating functional proteomics, genome engineering, and live-cell microscopy to the study of ciliopathies | 000 | 3 | NIH | 9/15/2022 | $249,000 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30EY021725 | P30 Center Core Grant for Vision Research | 003 | 12 | NIH | 9/2/2022 | $580,000 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K08CA266937 | Integrating pain-CBT into an mHealth analgesic support intervention for patients with chronic pain from advanced cancers | 000 | 1 | NIH | 6/29/2022 | $191,257 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK130174 | Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment | 001 | 1 | NIH | 8/29/2022 | $0 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK130174 | Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment | 000 | 1 | NIH | 7/14/2022 | $395,452 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI053108 | The Neuroimmunology of Viral Infection | 000 | 17 | NIH | 12/7/2021 | $440,794 |
| | 2022 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AI134719 | Activation of semi-invariant and diverse NKT cells with an adjuvant combination | 000 | 5 | NIH | 11/4/2021 | $367,120 |
|
